This review examines the role of metabolic connectivity based on fluorodeoxyglucose-PET in understanding brain network organization across neurologic disorders, with a focus on neurodegenerative diseases. The article explores key methodologies for metabolic connectivity study and highlights altered connectivity patterns in Alzheimer's, Parkinson's, frontotemporal dementia, and other conditions. It also discusses emerging applications, including single-subject analyses and brain-organ interactions.
Keywords: Brain connectivity; FDG; Fluorodeoxyglucose; Metabolic connectivity; Neuroimaging; PET.
Copyright © 2024 Elsevier Inc. All rights reserved.